United in Protection: vaccination is a show of solidarity!
Ahead of European Immunisation Week (EIW), taking place from 23 to 29 April 2023, Isabel de la Mata -principal advisor for Health and Crisis Management at the European Commission- talks about the benefits of lifelong vaccination
Improving Adult Vaccination Policy in Long-Term Care Settings. Technical Report.
With the World Immunization Week coming up, IFA has produced a study to deliver critical baseline data to help inform technical guidelines, as well as governmental and civil society dialogue and policy actions, to protect the health of LTC residents.
When to update COVID-19 vaccine composition
Vaccines against different SARS-CoV-2 variants have been approved, but continued surveillance is needed to determine when the antigen composition of vaccines should be updated, together with clinical studies to assess vaccine efficacy.
News
Reports
Policy & Recommendations
The European public health response to the COVID-19 pandemic: Lessons for future cross-border health threats
The early lessons from the pandemic underlined that challenges to health systems and economies, including supply chain problems and vaccine hesitancy, could no longer be overcome by European Union Member States acting alone.
The Journey to RSV Vaccines — Heralding an Era of Structure-Based Design
After a 1960s RSV vaccine was found to enhance disease in previously unexposed infants, development was put on hold. But structure-based design has led to effective RSV vaccines that now await approval.
Effectiveness of bivalent mRNA booster vaccination against SARS-CoV-2 Omicron infection, the Netherlands, September to December 2022
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron variant has been dominant in Europe since January 2022, causing large waves of infections because of high transmissibility and escape from vaccine- and infection-induced immunity.
Influenza vaccination in patients affected by diabetes
The effects of vaccination appear to be more effective when using higher-dose and quadrivalent vaccines, although subgroup-specific separate analyses in patients with diabetes are lacking.
COVID-19 Incidence and Mortality Among Unvaccinated and Vaccinated Persons Aged ≥12 Years by Receipt of Bivalent Booster Doses and Time Since Vaccination — 24 U.S. Jurisdictions, October 3, 2021–December 24, 2022
COVID-19 vaccine effectiveness decreased with waning of vaccine-derived immunity and emerging Omicron sublineages.
Impact of General Practitioner Education on Acceptance of an Adjuvanted Seasonal Influenza Vaccine among Older Adults in England
Seasonal vaccination against influenza and in-pandemic COVID-19 vaccination are top public health priorities; vaccines are the primary means of reducing infections and also controlling pressures on health systems.
A Pragmatic Randomized Feasibility Trial of Influenza Vaccines
We conducted a pragmatic, open-label, active-controlled, randomized feasibility trial in Danish citizens aged 65 to 79 years during the 2021–2022 influenza season.
Pharmacists are encouraged to speak to members of their community about getting both the flu and COVID-19 vaccines at the same time
This 2022-23 flu season in the Northern Hemisphere arrived earlier than expected and we are also seeing a concerning increase in the number of respiratory syncytial virus (RSV) cases.